Benelux Pharmaceuticals News
Benelux
Benelux Pharmaceuticals News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about Benelux Pharmaceuticals.
Latest Benelux Pharmaceuticals News
- French and Benelux stocks - Factors to watch on Dec 15 15 Dec 2009 06:54 GMT
... PARIS, Dec 15 (Reuters) - Below are company-related ... news and leading stories from French and Benelux newspapers which could have an impact on ... Jean-Francois Dehecq as non-executive chairman of the drug maker, Les Echos said. Veolia finance head Thomas ...
- DIARY - Belgium to Feb 26, 2010 15 Dec 2009 05:20 GMT
... indicator Feb CORPORATE/TREASURY/POLITICAL EVENTS MONDAY, DECEMBER 14 LUXEMBOURG - ArcelorMittal ( ) quarterly dividend payment ... ( ) fourth-quarter results BRUSSELS - Omega Pharma ( ) fourth-quarter, 2009 update BRUSSELS - Deceuninck ( ...
- New Research Report: Apparel Retail in Belgium 15 Dec 2009 06:54 GMT
... Datamonitor, now available Datamonitor's Apparel Retail in Belgium industry profile is an essential resource for ... Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, the ... & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. ...
- Access Pharmaceuticals Appoints Sales and Marketing Executive 15 Dec 2009 14:31 GMT
... positions at oncology focused companies including MGI Pharma, Genetics Institute, Wyeth Oncology, Aventis, Precision Therapeutics and ... into France, Central and Eastern Europe, the Benelux countries and the rest of Europe is anticipated ...
- Recently released market study: Computer Hardware in Belgium 15 Dec 2009 17:32 GMT
... Datamonitor, now available Datamonitor's Computer Hardware in Belgium industry profile is an essential resource for ... Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, the ... & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. ...
- The Ludwig Institute and Pro-Pharmaceuticals Collaborate to Test DAVANAT(R)'s Ability to Enhance the Function of Anti-Tumor T Lymphocytes 15 Dec 2009 13:02 GMT
... Pro-Pharmaceuticals' DAVANAT(R) Targets Galectin Receptors on Cancer Cells ... team at the Ludwig Institute in Brussels, Belgium, leaders in cancer immunology research, shows that blocking ...
- The Ludwig Institute and Pro-Pharmaceuticals Collaborate to Test DAVANAT®'s Ability to Enhance the Function of Anti-Tumor T Lymphocytes 15 Dec 2009 13:01 GMT
... team at the Ludwig Institute in Brussels, Belgium, leaders in cancer immunology research, shows that blocking ... vaccine,” said Anatole Klyosov, Ph.D., Chief Scientist, Pro-Pharmaceuticals, Inc. “Our pre-clinical, Phase I and Phase ...
- The Ludwig Institute and Pro-Pharmaceuticals Collaborate to Test Davanat's Ability to Enhance the Function of Anti-Tumor T Lymphocytes 15 Dec 2009 15:22 GMT
... team at the Ludwig Institute in Brussels, Belgium, leaders in cancer immunology research, shows that blocking ... vaccine,” said Anatole Klyosov, Ph.D., Chief Scientist, Pro-Pharmaceuticals, Inc. “Our pre-clinical, Phase I and Phase ...
- The Ludwig Institute and Pro-Pharmaceuticals Collaborate to Test DAVANAT(R)'s Ability to Enhance the Function of Anti-Tumor T Lymphocytes (BIZ) 15 Dec 2009 13:00 GMT
... Dr. Pierre van der Bruggen's team at the in Brussels, Belgium, leaders in cancer immunology research, shows that blocking the action of Galectin-3 improves the efficacy ...
- Intava Announces New In-Store Music and Promotions System and Global Music Deal With Jamendo 15 Dec 2009 13:43 GMT
... Intava, a leader in interactive media systems for retailers, restaurants ... products for retail, restaurants, and food and drug stores that can be scaled to thousands of ... and Software:Internet, Retail:Apparel, TravelandHospitality:Hotels, ,CA,BELLEVUE, WA and LUXEMBOURG Intava Announces New In-Store Music and Promotions ...
- NovaDel Receives Issue Notification for New U.S. Patent Covering its Oral Spray Drug Delivery Technology 15 Dec 2009 14:36 GMT
... its Oral Spray Drug Delivery Technology )--NovaDel Pharma Inc. (NYSE AMEX: NVD), today announced that it ... and 66 patents throughout Europe, including Austria, Belgium, Denmark, Finland, France, Germany, Great Britain, Greece, ... France, Germany, Great Britain, Greece, Ireland, Italy, Luxembourg, Monaco, Netherlands, Portugal, Spain, Sweden and Switzerland. ...
- Basilea's Toctino® recommended for approval in 15 additional European countries 15 Dec 2009 04:30 GMT
... 15 additional European countries Basel, Switzerland, Basilea Pharmaceutica Ltd. announces that Toctino (alitretinoin) was recommended ... has also received marketing authorization in Austria, Belgium, Canada, Finland, Luxemburg, the Netherlands, Spain and Switzerland. Further, Toctino has been ...
- Ablynx Initiates Phase I For ALX-0141 (anti-RANKL) 15 Dec 2009 13:51 GMT
... Initiates Phase I For ALX-0141 (anti-RANKL) GHENT, Belgium, 14 December 2009 - Ablynx [Euronext Brussels: ABLX] ... I study will investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single subcutaneous injection ...
- Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 15 Dec 2009 11:40 GMT
... which is being conducted at centres in Belgium and Serbia. The C-Cure trial will ultimately enroll ... extensive experience in developing and commercialising new pharmaceutical products and medical technologies and the Company's ...
- Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Hear 15 Dec 2009 11:51 GMT
... which is being conducted at centres in Belgium and Serbia. The C-Cure trial will ultimately enroll ... extensive experience in developing and commercialising new pharmaceutical products and medical technologies and the Company's ...
- Cardio3 BioSciences Completes Patient Enrollment in First Stage of Pivotal Trial of C-Cure in Heart Failure 15 Dec 2009 13:10 GMT
... which is being conducted at centres in Belgium and Serbia. The C-Cure trial will ultimately enroll ... extensive experience in developing and commercialising new pharmaceutical products and medical technologies and the Company's ...
- Research and Markets: Feed Acidifiers - Global Market Trends 15 Dec 2009 12:30 GMT
... animal species, given the market's shift from pharmaceutical products to natural feed and hygiene management. ... Lactic Acid Production in Spain and the Netherlands -- Nordbiochem to Assist Nitrokemia in Constructing ... GmbH (Austria) -- Furst-McNess (USA) -- Impextraco Belgium (Belgium) -- Jefo Nutrition, Inc. (Canada) -- ...
- EpiCept Provides Clinical and Business Update on Ceplene Program 15 Dec 2009 05:50 GMT
... will also assess the quantitative and qualitative pharmacodynamic effects of Ceplene/IL-2 on these patients by ... centers across Europe with sites in Sweden, Belgium, France, the U.K., Spain and Italy. EpiCept also ...
- Research and Markets: Feed Acidifiers - Global Market Trends (BIZ) 15 Dec 2009 12:33 GMT
... animal species, given the market's shift from pharmaceutical products to natural feed and hygiene management. ... Lactic Acid Production in Spain and the Netherlands -- Nordbiochem to Assist Nitrokemia in Constructing ... Position (Austria) -- Furst-McNess (USA) -- Impextraco Belgium (Belgium) -- ...
- EpiCept Provides Clinical and Business Update on Ceplene Program (BIZ) 15 Dec 2009 05:50 GMT
... will also assess the quantitative and qualitative pharmacodynamic effects of Ceplene/IL-2 on these patients by ... centers across Europe with sites in Sweden, Belgium, France, the U.K., Spain and Italy. also announced ...
- Encouraging results from DAVANAT in combination with chemotherapies and biologics 15 Dec 2009 14:36 GMT
... team at the Ludwig Institute in Brussels, Belgium, leaders in immunology research, shows that blocking the ... vaccine,” said Anatole Klyosov, Ph.D., Chief Scientist, Pro-Pharmaceuticals, Inc. “Our pre-clinical, Phase I and Phase ...
- Vendor unveils HIV-specific electronic medical record 15 Dec 2009 16:55 GMT
... among healthcare organizations, including laboratories, radiologists and pharmacies. The solution includes features that automate certain ... said Werner Verbiest, general manager worldwide of Belgium-based Tibotec. "We will continue to explore new ...
- "Confectionery in Italy" is now available at Fast Market Research 15 Dec 2009 05:55 GMT
... constant annual average exchange rates. Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, ... Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, the ... & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. ...
- Recently released market study: Global Confectionery 15 Dec 2009 05:55 GMT
... Mexico, Venezuela, and the US. Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, ... Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, the ... & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. ...
- EpiCept Provides Clinical and Business Update on Ceplene Program Announces New Initiatives to Expand Label, Drive Product Adoption 15 Dec 2009 06:11 GMT
... will also assess the quantitative and qualitative pharmacodynamic effects of Ceplene/IL-2 on these patients by ... centers across Europe with sites in Sweden, Belgium, France, the U.K., Spain and Italy. ...
Powered by 
Benelux Pharmaceuticals News Sections
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
| |
- FDA actions in brief, December 2009 (Zirgan, Welchol, Sculptra Aesthetic, Berinert, Crestor, Agriflu, Byetta) [15 Dec 2009 - 05:11]
- FDA actions in brief, December 2009 (Zirgan, Welchol, Sculptra Aesthetic, Berinert, Crestor, Agriflu, Byetta) [14 Dec 2009 - 16:56]
- AstraZeneca hit by Crestor court decision as panel evaluates Jupiter data [14 Dec 2009 - 13:19]
- AstraZeneca fails to win judgment in Crestor case [14 Dec 2009 - 08:40]
- Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site [13 Dec 2009 - 04:51]
Pharmaceutical Industry Today
|